Charles River Laboratories | CRL - Pre Tax Profit



Charles River Laboratories reported $71.42M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Agilent USD 366M 106M Jul/2025
Align Technology USD 173.52M 33.07M Jun/2025
Bio-Rad Laboratories USD 414M 330.6M Jun/2025
Bruker USD 500K 24.6M Jun/2025
Cardinal Health USD 384M 281M Jun/2025
Charles River Laboratories USD 71.42M 35.44M Jun/2025
Cigna USD 2.02B 373M Jun/2025
CVS Health USD 1.65B 970M Jun/2025
Danaher USD 655M 474M Jun/2025
Dentsply International USD -153000000 197M Jun/2025
Elevance Health USD 2.29B 505M Jun/2025
Galapagos EUR -156367000 175.4M Mar/2025
Hologic USD 235M 263.5M Jun/2025
Humana USD 741M 950M Jun/2025
Illumina USD 306M 124M Jun/2025
Incyte USD 558.01M 323.82M Jun/2025
IQVIA Holdings USD 322M 1000K Jun/2025
Laboratory Of America USD 304.7M 29.5M Jun/2025
Lonza CHF 624M 197M Dec/2024
McKesson USD 1.05B 464M Jun/2025
Merck EUR 829M 127M Jun/2025
Mettler Toledo International USD 248.66M 46.72M Jun/2025
Novartis USD 4.53B 124M Jun/2025
Pfizer USD 3.04B 259M Jun/2025
Quest Diagnostics USD 393M 117M Jun/2025
Revvity USD 171.65M 119.26M Jun/2025
Thermo Fisher Scientific USD 1.62B 1.01B Mar/2025
United Therapeutics USD 408.4M 15.1M Jun/2025
UnitedHealth USD 4.39B 3.71B Jun/2025
Waters USD 177.69M 34.8M Jun/2025
West Pharmaceutical Services USD 162M 51.5M Jun/2025